Abstract
CONTACT: Dr. Evelyn Walter IPF Institute for Pharmaeconomic Research Wolfengasse 4/7 1010 Vienna, Austria Tel +43-1-5132007-13 Fax +43-1-5132007-15 Email: e.walter@ipf-ac.at Web: www.ipf-ac.at Objectives Toxoplasma infection during pregnancy can present a serious hazard to the fetus including lifelong disabilities of connatal infected children. This foodborne illness is a common burden worldwide. Prevention strategies of the health care providers are diverse. In Austria, the maternal toxoplasma screening has been implemented four decades ago. The aim of this study was to determine the cost-effectiveness of the maternal toxoplasma screening.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
